PROS1 and COVID-19: Fourthly, we used a single-low dose of NILV particles (1 × 105) i.n. whereas a recent study, which analyzed the protective effect of NILV expressing S protein in the Syrian hamster model of COVID-19, primed systemically and boosted with a high dose of NILV particles (1 × 108) i.n (97).